Results 71 to 80 of about 9,892 (240)

The Concise Guide to PHARMACOLOGY 2025/26: G protein‐coupled receptors

open access: yesBritish Journal of Pharmacology, Volume 182, Issue S1, Page S24-S151, December 2025.
The Concise Guide to Pharmacology 2025/26 marks the seventh edition in this series of biennial publications in the British Journal of Pharmacology. Presented in landscape format, the guide provides a comparative overview of the pharmacology of drug target families. The concise nature of the Concise Guide refers to the style of presentation, being clear,
Stephen P. H. Alexander   +206 more
wiley   +1 more source

Idiosyncratic hepatic toxicity in autosomal dominant polycystic kidney disease (ADPKD) patient in combined treatment with tolvaptan and amoxicillin/clavulanic acid: a case report

open access: yesBMC Nephrology, 2019
Background Autosomal dominant polycystic kidney disease (ADPKD) is a hereditary disease characterized by the presence of renal cysts. Over time the expanding cysts lead to progressive renal failure.
Angela Maria Pellegrino   +3 more
doaj   +1 more source

Urinary markers in heart failure – types, timing and thresholds. European Journal of Heart Failure expert consensus document

open access: yesEuropean Journal of Heart Failure, Volume 27, Issue 11, Page 2372-2396, November 2025.
Pathophysiologic mechanisms of heart failure (HF) (i.e. renin–angiotensin–aldosterone system [RAAS], congestion, and inflammation), together with patient‐related factors such as diabetes, hypertension, and chronic kidney disease (CKD), contribute to kidney function decline and glomerular or tubular injury.
Masatake Kobayashi   +14 more
wiley   +1 more source

Tolvaptan [PDF]

open access: yesBritish Journal of Clinical Pharmacology, 2011
Eline A, Dubois   +2 more
openaire   +3 more sources

Renal ultrasonography predicts worsening renal function in patients with heart failure under tolvaptan administration

open access: yesESC Heart Failure
Aims Renal dysfunction in patients with chronic heart failure predicts a poor prognosis. Tolvaptan has a diuretic effect in patients with chronic kidney disease and heart failure without adverse effects on renal function.
Nobukiyo Tanaka   +14 more
doaj   +1 more source

Impact of non‐cardiovascular factors on cardiovascular death in acute decompensated heart failure: Enhancing predictive models with frailty and comorbid constipation—the Constipation and Frailty Augmented AHEAD score

open access: yesGeriatrics &Gerontology International, Volume 25, Issue 10, Page 1341-1349, October 2025.
We developed the CFA‐AHEAD score by incorporating constipation and frailty into the conventional AHEAD model. This new score significantly improves the prediction of mortality in patients with acute decompensated heart failure. Simple and practical, the CFA‐AHEAD score enhances clinical risk stratification and might support personalized patient ...
Tomoaki Ishida   +13 more
wiley   +1 more source

Potential amelioration of liver function by low-dose tolvaptan in heart failure patients

open access: yesToxicology Reports
Aim: This study aimed to evaluate the relationships between the pharmacokinetics of tolvaptan and its metabolites (DM-4103 and DM-4107) and liver injury in heart failure patients, using relevant laboratory test values and markers of hepatocyte injury and
Yasuaki Mino   +8 more
doaj   +1 more source

The Association of Hyponatremia with Race, Ethnicity, and Gender in Patients Admitted for Acute Decompensated Heart Failure Diagnoses [PDF]

open access: yes, 2018
Background: Hyponatremia, defined by a serum sodium concentration less than 135 mEq/L, is seen in approximately 25% of patients admitted with congestive heart failure (CHF).
Alvarez, MD, Rene   +2 more
core   +1 more source

PHS48 Cost-Effectiveness Analysis of Tolvaptan for Hyponatreamia in South Korea [PDF]

open access: yes, 2005
Lanz, AlfredoPla general de la part frontal de dona ajaguda sobre un suport en forma de llit o taula. Va ser donada per l'autor, Alfredo Lanz, i simbolitza el mar Mediterrani.
Kang, H.J.   +3 more
core   +1 more source

Mechanisms governing GPCR anterograde transport

open access: yesFEBS Letters, Volume 599, Issue 17, Page 2420-2438, September 2025.
G protein‐coupled receptors (GPCRs) determine human physiology by transducing ligand binding into intracellular signaling. The transport of nascent GPCRs from the endoplasmic reticulum to the cell surface is critical for cellular responsiveness. We discuss mechanisms regulating GPCR trafficking through secretory organelles, retention of disease‐related
Kevin Assoumou   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy